Alzheimer's Disease Trial, Not Yet Recruiting NCT07521722 Sponsor: Barcelonabeta Brain Research Center, Pasqual Maragall Foundation Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07521722
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 50 and 75 years old at the time of signing the consent form, who have no cognitive impairment.
  • People who are interested in taking part, are able to follow the study procedures, and understand that all tests are being done for research purposes.
  • People who are willing to take part in all study activities, including having study information collected, completing thinking and brain health tests, and having blood samples taken.
  • People who are willing to sign a consent form and agree that they will not receive research results that are not considered clinically relevant to them.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who show signs of cognitive decline, as measured by a standard clinical assessment tool called the CDR (a score above zero indicates some level of decline).
  • People who have noticed problems with their memory or thinking and have sought medical help for this at any point in their life.
  • People who have significant health conditions that could affect how study results are interpreted, including hearing or vision problems, an active cancer that is currently being treated (smaller localised tumours may not apply — confirm with trial site), or any other condition the study doctor believes could interfere with the study.
  • People who have been diagnosed with a major psychiatric condition (such as major depression, bipolar disorder, or schizophrenia) or any condition that affects thinking and mental abilities.
  • People who have had a significant brain injury, a large stroke (either caused by a blocked or burst blood vessel), a brain tumour, or any other event or treatment that may have caused brain damage, such as chemotherapy or radiation to the brain.
  • People who have Parkinson's disease, epilepsy with frequent seizures (more than once a month in the past year) that requires treatment, multiple sclerosis, or any other condition that causes progressive brain deterioration.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34‭ 933263190

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Registry
ClinicalTrials.gov
Start date
27 April 2026
Est. completion
27 April 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Plasma levels of Alzheimer's disease blood-based biomarkers across ethnic groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov